Medable to Host Digital Trial Events at J.P. Morgan Healthcare Conference 2020
Summary
Panelists include panel moderator Amir Kalali of CNS, Rasmus Hogreffe of Leo Pharma, Mads Dalsgaard of Lundbeck, Ritesh Patel of Ogilvy, and Dr. Michelle Longmire of Medable. Tuesday, January 14th, Dr. David Fajgenbaum, author of “Chasing My Cure” will join Dr. Michelle Longmire, CEO, and co-founder of Medable, in an open conversation, discussing Dr. Fajgenbaum’s heroic journey discovering a cure for Castleman’s disease. Dr. Michelle Longmire, CEO, and co-founder will present at the Digital Medicine and Medtech Showcase 2020, January 13, 2020, at the Parc 55 Hotel in San Francisco, California. Dr. Longmire will also be speaking at the Phase2 and HealthX annual event, January 14, 2020, at the Monroe, 473 Broadway in San Francisco Medable is a privately held, venture-backed company headquartered in Palo Alto, California. Medable is pioneering a new category of life science technologies that replace the stagnant and siloed data of traditional ePRO, eCOA, EDC, and eSource with an intelligent and unified end-to-end (E2E) platform for clinical trial execution.